Biosimilar Versus Originator Pegfilgrastim for Preventing Chemotherapy-Induced Neutropenia: A Phase III Randomized, Multicenter, Evaluator-Blinded, Noninferiority Study.

Autor: Kowalyszyn, Ruben D.¹ (AUTHOR), Fein, Luis E.² (AUTHOR), Richardet, Martin E.³ (AUTHOR), Varela, Mirta S.⁴ (AUTHOR), Ortiz, Eduardo⁵ (AUTHOR), Micheri, Cristian⁶ (AUTHOR), Zarba, Juan J.⁷ (AUTHOR), Kahl, Susana⁸ (AUTHOR), Klimovsky, Ezequiel⁹ (AUTHOR) eklimovsky@quid-consulting.com, Federico, Andrea A.⁹ (AUTHOR), Cassini, Jorge H.¹⁰ (AUTHOR), Cortese, Gustavo¹¹ (AUTHOR), Lago, Nestor¹² (AUTHOR)

Publikováno v: JCO Global Oncology. 3/24/2022, Vol. 8, p1-8. 8p.